Therefore, the current study is aimed to investigate the possible effects of DOT1L on lung fibrosis and inflammation responses both in TGF-β1-induced fibroblasts and in bleomycin-induced mouse models of IPF. This evidence concerns the gene TGFB1 and pulmonary fibrosis.